145 related articles for article (PubMed ID: 36930264)
1. The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications.
Torabinejad S; Miro C; Barone B; Imbimbo C; Crocetto F; Dentice M
Eur Thyroid J; 2023 Jun; 12(3):. PubMed ID: 36930264
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer.
Miro C; Di Giovanni A; Murolo M; Cicatiello AG; Nappi A; Sagliocchi S; Di Cicco E; Morra F; Celetti A; Pacifico F; Imbimbo C; Crocetto F; Dentice M
Cancer Lett; 2022 Apr; 532():215581. PubMed ID: 35134514
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormones in male reproductive development: evidence for direct crosstalk between the androgen and thyroid hormone axes.
Flood DE; Fernandino JI; Langlois VS
Gen Comp Endocrinol; 2013 Oct; 192():2-14. PubMed ID: 23524004
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of androgen action--a historical perspective.
Brinkmann AO
Methods Mol Biol; 2011; 776():3-24. PubMed ID: 21796517
[TBL] [Abstract][Full Text] [Related]
5. Regulation of thyroid hormone-, oestrogen- and androgen-related genes by triiodothyronine in the brain of Silurana tropicalis.
Duarte-Guterman P; Trudeau VL
J Neuroendocrinol; 2010 Sep; 22(9):1023-31. PubMed ID: 20626568
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormones and androgens differentially regulate gene expression in testes and ovaries of sexually mature Silurana tropicalis.
Campbell DEK; Langlois VS
Gen Comp Endocrinol; 2018 Oct; 267():172-182. PubMed ID: 29990494
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.
Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M
Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel androgen receptor target genes in prostate cancer.
Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
[TBL] [Abstract][Full Text] [Related]
10. Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor.
Hong MY; Seeram NP; Heber D
J Nutr Biochem; 2008 Dec; 19(12):848-55. PubMed ID: 18479901
[TBL] [Abstract][Full Text] [Related]
11. Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer.
Audet-Walsh É; Yee T; Tam IS; Giguère V
Endocrinology; 2017 Apr; 158(4):1015-1021. PubMed ID: 28324044
[TBL] [Abstract][Full Text] [Related]
12. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
[TBL] [Abstract][Full Text] [Related]
13. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
14. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.
Diao X; Chen X; Pi Y; Zhang Y; Wang F; Liu P; Gao Y; Wang X; Yang S; Lu S
Oncol Rep; 2018 Aug; 40(2):1174-1184. PubMed ID: 29917167
[TBL] [Abstract][Full Text] [Related]
16. Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
Li J; Ding Z; Wang Z; Lu JF; Maity SN; Navone NM; Logothetis CJ; Mills GB; Kim J
PLoS One; 2011; 6(12):e28840. PubMed ID: 22194926
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor involvement in the progression of prostate cancer.
Suzuki H; Ueda T; Ichikawa T; Ito H
Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.
Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL
Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697
[TBL] [Abstract][Full Text] [Related]
19. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.
Liu XH; Kirschenbaum A; Yao S; Liu G; Aaronson SA; Levine AC
Cancer Res; 2007 Jun; 67(12):5747-53. PubMed ID: 17575141
[TBL] [Abstract][Full Text] [Related]
20. Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
Aksoy O; Pencik J; Hartenbach M; Moazzami AA; Schlederer M; Balber T; Varady A; Philippe C; Baltzer PA; Mazumder B; Whitchurch JB; Roberts CJ; Haitel A; Herac M; Susani M; Mitterhauser M; Marculescu R; Stangl-Kremser J; Hassler MR; Kramer G; Shariat SF; Turner SD; Tichy B; Oppelt J; Pospisilova S; Hartenbach S; Tangermann S; Egger G; Neubauer HA; Moriggl R; Culig Z; Greiner G; Hoermann G; Hacker M; Heery DM; Merkel O; Kenner L
Int J Cancer; 2021 Feb; 148(3):731-747. PubMed ID: 33034050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
